The Body: The Complete HIV/AIDS Resource
Sign up for free e-mail updates!The Body en Espanol
Please Note: Due to volume considerations, not all questions can be answered. Questions most likely to be answered will be those of general interest to a broad group of visitors to this forum. Questions pertaining to a specific case; requests for diagnosis, medical advice, or second opinion; or requests for opinions about untested alternative therapies will generally not be answered.

This Forum is made possible in part by Gilead and GlaxoSmithKline.

Ask the Experts about Choosing Your Meds
Recent AnswersAsk a Question

 

To medicate or to wait (that is the question)
May 17, 2008

I am a 30 yo male who was diagnosed hiv+ about two months ago, have a cd4 count of 473, and a viral load of 38410. my resistance tests showed Im resistant to sustiva, and viramune. My doctor says I should consider starting meds and to read up on and choose an NRTI and a PI. What would be your suggestions for the the most appropriate first time medication combinations. I would like to find something with minimal bothersome side effects, and the most options for future medications. Ive read up on each class of medications, but in your medical experience which have you found to be easiest for beginners? I look forward to your reply. Thanks

Response from Dr. Young

Thanks for your post.

I'm not entirely in agreement with your doctor that you need to start medications in the near future; but in any event, getting the best information about what medications to start with is very reasonable.

In our clinic, we frequently use either of the DHHS-recommended nuke combos, namely Truvada or Epzicom. If you have issues with kidney disease (or risks), then Truvada's probably not the best choice. Similarly, if your genetic testing shows a high risk gene for abacavir allergic reaction (called HLA B5701), you definitely should not receive Epzicom.

As for PIs, we've largely stopped using Kaletra for first-line treatment because of better responses (and fewer clinical side effects) with Norvir-boosted alternatives, Lexiva and Reyataz. In our clinic (in contrast to national trends), we use more Lexiva than Reyataz, because our patients prefer not to have any diet restriction or risk of yellowing of the skin. If Norvir isn't well tolerated, then there are some options for alternative non-boosted regimens.

In your case, with transmitted NNRTI resistance, preserving future treatment options makes a lot of sense; using a boosted PI is reasonable in this regard, since patients failing first-line boosted PIs rarely have broad cross resistance.

I hope this helps,

BY



Terms of Use
Please remember that this forum is designed for educational purposes only, and experts are not engaged through this forum in rendering legal or medical advice or professional services. Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither The Body nor any sponsor is the publisher or speaker of posted visitors' questions or the experts' material.

Questions and messages posted to this forum are not statements of advice, opinion, or information of The Body, Body Health Resources Corporation or any sponsor of this forum. While neither The Body nor Body Health Resources Corporation regularly reviews posted content, we reserve the right to delete, move, or edit postings if we deem it appropriate under the circumstances. Visitors submitting questions remain solely responsible for the content of their messages.

Information provided by experts is general only and should not be used for diagnosing or treating a health problem or a disease, or relied upon as legal or other professional advice. This information is not a substitute for professional advice or care. If you have or suspect you may have a health or legal problem, you should consult your own health care provider or your attorney.

Copyright notice.